XJZY: Acetate Dexamethasone Tablets 0.5mg specification passed the consistency evaluation

Zhitong
2025.10.13 09:19

XJZY announced that it recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration regarding Dexamethasone Acetate Tablets. The company's Dexamethasone Acetate Tablets have added a new specification of 0.5mg, which has passed the consistency evaluation of quality and efficacy for generic drugs

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer